Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
Tirzepatide use was associated with a little more than double the odds—115 percent—of developing PDR compared with those not on the medication, with most cases occurring in patients who already had mild retinal damage from diabetes.
Endocrinology, Diabetes, Metabolism August 22nd 2025
Cleveland Clinic Journal of Medicine (CCJM)
Diabetic retinopathy is the only leading cause of blindness that has not experienced a decrease in age-standardized prevalence between 1990 and 2020, highlighting the urgent need for improved prevention and management strategies.
Endocrinology, Diabetes, Metabolism August 20th 2024